Abstract
The poor prognosis for hepatocellular carcinoma (HCC) is associated with its high rate of recurrence in the cirrhotic liver. Therefore, development of effective strategies for preventing recurrence and secondary tumors will improve the clinical outcome of HCC patients. A malfunction of the retinoid X receptor-α (RXRα) due to phosphorylation by the Ras-MAPK signaling pathway is profoundly associated with liver carcinogenesis, and thus, may be a promising target for HCC chemoprevention. Acyclic retinoid (ACR), which inhibits Ras-MAPK activation and RXRα phosphorylation, successfully prevents HCC recurrence, thus improving patient survival. The fundamental concept of HCC chemoprevention by ACR is “clonal deletion,” which is defined as the removal of latent malignant clones from the liver before they expand into clinically detectable HCC. “Combination chemoprevention” using ACR as a key drug holds great promise of a new effective strategy for the prevention of HCC because of its synergism. ACR is also expected to prevent the development of HCC in obese people, who are at an increased risk to HCC, because this agent significantly inhibits obesity-related liver tumorigenesis in the rodent model. Here, we review the detailed effects of ACR on preventing HCC development, especially based on the results of our basic and clinical research.
Keywords: Acyclic retinoid, chemoprevention, clonal deletion, combination therapy, HCC, obesity, phosphorylated RXRα, lectin-reactive α-fetoprotein factor 3, branched chain amino acids, diethylnitrosamine, extracellular signal-regulated kinase, hepatitis B virus, hepatocellular carcinoma, hepatitis C virus, histone deacetylase, human epidermal growth factor receptor-2, interferon
Current Cancer Drug Targets
Title:Role of Acyclic Retinoid in the Chemoprevention of Hepatocellular Carcinoma: Basic Aspects, Clinical Applications, and Future Prospects
Volume: 12 Issue: 9
Author(s): Masahito Shimizu, Kenji Imai, Koji Takai and Hisataka Moriwaki
Affiliation:
Keywords: Acyclic retinoid, chemoprevention, clonal deletion, combination therapy, HCC, obesity, phosphorylated RXRα, lectin-reactive α-fetoprotein factor 3, branched chain amino acids, diethylnitrosamine, extracellular signal-regulated kinase, hepatitis B virus, hepatocellular carcinoma, hepatitis C virus, histone deacetylase, human epidermal growth factor receptor-2, interferon
Abstract: The poor prognosis for hepatocellular carcinoma (HCC) is associated with its high rate of recurrence in the cirrhotic liver. Therefore, development of effective strategies for preventing recurrence and secondary tumors will improve the clinical outcome of HCC patients. A malfunction of the retinoid X receptor-α (RXRα) due to phosphorylation by the Ras-MAPK signaling pathway is profoundly associated with liver carcinogenesis, and thus, may be a promising target for HCC chemoprevention. Acyclic retinoid (ACR), which inhibits Ras-MAPK activation and RXRα phosphorylation, successfully prevents HCC recurrence, thus improving patient survival. The fundamental concept of HCC chemoprevention by ACR is “clonal deletion,” which is defined as the removal of latent malignant clones from the liver before they expand into clinically detectable HCC. “Combination chemoprevention” using ACR as a key drug holds great promise of a new effective strategy for the prevention of HCC because of its synergism. ACR is also expected to prevent the development of HCC in obese people, who are at an increased risk to HCC, because this agent significantly inhibits obesity-related liver tumorigenesis in the rodent model. Here, we review the detailed effects of ACR on preventing HCC development, especially based on the results of our basic and clinical research.
Export Options
About this article
Cite this article as:
Shimizu Masahito, Imai Kenji, Takai Koji and Moriwaki Hisataka, Role of Acyclic Retinoid in the Chemoprevention of Hepatocellular Carcinoma: Basic Aspects, Clinical Applications, and Future Prospects, Current Cancer Drug Targets 2012; 12 (9) . https://dx.doi.org/10.2174/15680096112091119
DOI https://dx.doi.org/10.2174/15680096112091119 |
Print ISSN 1568-0096 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5576 |
Related Books

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Gold Nanoparticles Enhance the Toluidine Blue-Induced Lethal Photosensitisation of Staphylococcus aureus
Current Nanoscience Is it Possible to Reduce the Incident of Colorectal Cancer by Modifying Diet and Lifestyle?
Current Cancer Therapy Reviews PIP3 Regulation as Promising Targeted Therapy of Mast-Cell-Mediated Diseases
Current Pharmaceutical Design Review of Noscapine and its Analogues as Potential Anti-Cancer Drugs
Mini-Reviews in Organic Chemistry An Insight of Molecular Mechanisms and Patents of Biomarkers of Human Papilloma Virus Associated with Cancer : A Review
Recent Patents on Biomarkers Hypoxia-Inducible Factor-1 as Regulator of Angiogenesis in Rheumatoid Arthritis - Therapeutic Implications
Current Medicinal Chemistry Attributes, Performance, and Gaps in Current & Emerging Breast Cancer Screening Technologies
Current Medical Imaging Review of Pediatric Osteoarticular Infections
Reviews on Recent Clinical Trials Amyloid β -Protein Assembly as a Therapeutic Target of Alzheimers Disease
Current Pharmaceutical Design Life and Death of Nerve Cells: Therapeutic Cytokine Signaling Pathways
Current Signal Transduction Therapy Recent Advances in Substrate Identification of Protein Kinases in Plants and Their Role in Stress Management
Current Genomics Pd/C-catalyzed Synthesis of (E)-2-arylmethylideneindolin-3-ols Under Ultrasound: Their Initial Evaluation as Potential Anti-proliferative Agents
Letters in Drug Design & Discovery Lymphatics and Inflammation
Current Medicinal Chemistry Translational Science: Epistemology and the Investigative Process
Current Genomics Therapeutic Strategies for Hepatitis B virus-Associated Hepatocellular Carcinoma
Current Drug Targets Patent Selections
Recent Patents on CNS Drug Discovery (Discontinued) Spirooxindoles as Potential Pharmacophores
Mini-Reviews in Medicinal Chemistry Subject Index To Volume 3
Current Pharmaceutical Biotechnology Novel Applications of the Paired-End diTag (PET) Technology in Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine In Vitro Antitumoral Activity of Palladium(II) and Platinum(II) Complexes with O,O'-Dialkyl Esters of Ethylene-bis(S)-Leucine
Letters in Drug Design & Discovery